Both granulocyte colony stimulating factor (G-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF) have been used to manage neutropenia in cancer chemotherapy, but neither of them is found to be superior to the other [30]. Here, CSF2 is linked to neutropenia.